Business Unit Manager Parkinson Disease and HCV AHA
About the job
- A relevant university degree in Science, Applied Science, or Business is required.
- Relevant experience and a proven track record of success in marketing or sales within the biotechnology or pharmaceutical industry are required.
- A strong performance track record with tangible business and people results is required.
- Knowledge of the external stakeholder environment and market access issues is required.
- Knowledge of the healthcare and pharmaceutical environment is required.
- Ability to translate strategies into actionable and realistic marketing actions is required.
- Ability to lead, motivate, and coordinate cross-functional teams is required.
- Business acumen and knowledge of sales and marketing are required.
- Solid knowledge of strategic and tactical marketing principles and techniques, including digital knowledge, is required.
- Solid knowledge of finance principles and processes is required.
- English language proficiency, verbally and in writing, is required.
- Effectively manage and execute all marketing and sales-related brand activities according to brand plans within the therapeutic area and business unit.
- Oversee product development and implementation of commercial brand strategy and tactical brand activities, and deliver sales performance to maximize or exceed brand sales and margin.
- Maximize brand sales and margin revenue through effective management and execution of brand activities as per the brand plan and through leadership, contribution, and participation in brand team activities.
- Hold accountability and responsibility for allocated brand profit and loss and financial planning, including the Financial Plan, LBE, and LRP.
- Oversee product and team management, including product budget expenditures and staff development.
- Supervise and control sales forecasting and sales plan inputs, including annual budget and sales preparation and monthly and quarterly updates.
- Support product market expansion through innovative commercial programs; develop views on brand issues and competitive positioning; and maintain and develop in-depth insight to anticipate stakeholder needs.
- Develop and coach talent and build succession plans to ensure continuous high performance and an engaged talent pipeline in Sales and Marketing, if applicable.
- Build cross-functional cooperation among key stakeholders and effective multidisciplinary teams; ensure timely, qualitative market-intelligence information flow to Brand Teams and communication of brand strategy and tactics from Brand Teams to In-Field Teams to optimize execution.
- Liaise with relevant Area and Global functions to integrate global and area strategies and tactics into local brand planning and execution, and facilitate development and alignment of global and area brand vision and strategic objectives.
- Perform other duties as assigned by the manager.
About the company
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Company Size
10,001+
Company Stage
IPO
Headquarters
North Chicago, Illinois
Founded
1888
Get referred to AbbVie
See people who can refer or advise you
Simplify's Take
What believers are saying
- Apogee acquisition closed in 2026, expanding AbbVie’s immunology pipeline beyond Skyrizi and Rinvoq.
- EU approvals for RINVOQ and EPKINLY in September 2026 broaden ex-U.S. revenue.
- JUVMO launches in October 2026, adding a fresh neuroscience revenue line.
What critics are saying
- Humira, Skyrizi, and Rinvoq concentration keeps AbbVie exposed if immunology growth slows in 2027.
- Niaspan antitrust MDL and Biocell ALCL settlements carried $1.7 billion litigation accrual by June 2026.
- Generic ubrogepant and atogepant suits threaten Ubrelvy and Qulipta exclusivity within years.
What makes AbbVie unique
- Skyrizi and Rinvoq anchor AbbVie’s post-Humira immunology franchise across 11 EU RINVOQ indications.
- JUVMO’s September 28, 2026 FDA approval gives AbbVie first-in-class Parkinson’s D1/D5 therapy.
- AbbVie pairs blockbuster cash flows with Apogee, Iambic, and Valkai deal-making.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Remote Work Options
- Flexible Work Hours
- Professional Development Budget